Moleculin Biotech- Believes Existing Cash and Cash Equivalents as of June 30 to Be Sufficient to Fund Planned Operations Into Q4
Moleculin biotech- 相信截至6月30日的現金及現金等價物已足夠資助計劃,在第四季度之前進行運營
Moleculin Biotech- Believes Existing Cash and Cash Equivalents as of June 30 to Be Sufficient to Fund Planned Operations Into Q4
Moleculin biotech- 相信截至6月30日的現金及現金等價物已足夠資助計劃,在第四季度之前進行運營
譯文內容由第三人軟體翻譯。